Document Detail


New and efficient routes to biomolecules substituted with cyclopentadienyltricarbonylrhenium and -technetium derivatives.
MedLine Citation:
PMID:  11446631     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The small, compact, robust, and nonpolar units of [CpM(CO)3] (M = Re, Tc) coupled with biomolecules may be considered as bioorganometallic entities of potential interest in the field of medicinal chemistry. However, the short half-life of useful radionuclides (186Re t1/2 = 3.7 d, 188Re t1/2 = 16.8 h, 99mTc t1/2 = 6 h), the risks inherent in their use, and their cost have led chemists to search for novel synthetic strategies that allow the rapid introduction of the [CpM(CO)3] moiety as a late step in the course of synthesizing the target molecule. The present paper describes different strategies recently reported in the literature to tackle this problem.
Authors:
F Le Bideau; M Salmain; S Top; G Jaouen
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chemistry (Weinheim an der Bergstrasse, Germany)     Volume:  7     ISSN:  0947-6539     ISO Abbreviation:  Chemistry     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-07-11     Completed Date:  2001-07-26     Revised Date:  2009-08-04    
Medline Journal Info:
Nlm Unique ID:  9513783     Medline TA:  Chemistry     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  2289-94     Citation Subset:  IM    
Affiliation:
UMR 7576 CNRS, Ecole Nationale Supérieure de Chimie de Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / drug therapy
Chemistry, Pharmaceutical / methods
Cyclopentanes / chemistry*
Estrogens / chemical synthesis*,  chemistry
Half-Life
Molecular Structure
Octreotide / chemistry
Organometallic Compounds / chemical synthesis*,  chemistry
Organotechnetium Compounds / chemical synthesis*,  chemistry
Peptides / chemistry
Proteins / chemistry
Radioisotopes / chemistry*,  diagnostic use
Radiopharmaceuticals / chemical synthesis*,  chemistry
Rhenium / chemistry*,  diagnostic use
Selective Estrogen Receptor Modulators / chemistry
Structure-Activity Relationship
Tamoxifen / analogs & derivatives,  chemical synthesis*,  chemistry,  therapeutic use
Technetium Tc 99m Sestamibi / chemistry
Chemical
Reg. No./Substance:
0/Cyclopentanes; 0/Estrogens; 0/Organometallic Compounds; 0/Organotechnetium Compounds; 0/Peptides; 0/Proteins; 0/Radioisotopes; 0/Radiopharmaceuticals; 0/Selective Estrogen Receptor Modulators; 10540-29-1/Tamoxifen; 109581-73-9/Technetium Tc 99m Sestamibi; 6317-25-5/fulvene; 7440-15-5/Rhenium; 83150-76-9/Octreotide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The College of Physicians in the nineteenth century.
Next Document:  Pre-reactive complexes in mixtures of water vapour with halogens: characterisation of H2O...ClF and ...